Related references
Note: Only part of the references are listed.NMR metabolic fingerprints of murine melanocyte and melanoma cell lines: application to biomarker discovery
Arquimedes Paixao de Santana-Filho et al.
SCIENTIFIC REPORTS (2017)
Lipid metabolic reprogramming in cancer cells
S. Beloribi-Djefaflia et al.
ONCOGENESIS (2016)
Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells
Andreas Koch et al.
ONCOTARGET (2015)
Prognostic value of pretreatment serum lactate dehydrogenase level in patients with solid tumors: a systematic review and meta-analysis
Jiao Zhang et al.
SCIENTIFIC REPORTS (2015)
The role of sphingomyelin and sphingomyelin synthases in cell death, proliferation and migration-from cell and animal models to human disorders
Makoto Taniguchi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2014)
Emerging trends in the epidemiology of melanoma
V. Nikolaou et al.
BRITISH JOURNAL OF DERMATOLOGY (2014)
Metabolomics in diagnosis and biomarker discovery of colorectal cancer
Aihua Zhang et al.
CANCER LETTERS (2014)
Whole transcriptome RNA-seq analysis: tumorigenesis and metastasis of melanoma
Hua Zhao et al.
GENE (2014)
Site-specific metabolic phenotypes in metastatic breast cancer
Hye Min Kim et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
1H NMR metabolomics study of metastatic melanoma in C57BL/6J mouse spleen
Xuan Wang et al.
METABOLOMICS (2014)
Rad6 is a Potential Early Marker of Melanoma Development
Karli Rosner et al.
TRANSLATIONAL ONCOLOGY (2014)
OmniSpect: An Open MATLAB-Based Tool for Visualization and Analysis of Matrix-Assisted Laser Desorption/Ionization and Desorption Electrospray Ionization Mass Spectrometry Images
R. Mitchell Parry et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2013)
LipidBlast in silico tandem mass spectrometry database for lipid identification
Tobias Kind et al.
NATURE METHODS (2013)
Comparative analysis of volatile metabolomics signals from melanoma and benign skin: a pilot study
T. Abaffy et al.
METABOLOMICS (2013)
Studies of Secondary Melanoma on C57BL/6J Mouse Liver Using 1H NMR Metabolomics
Ju Feng et al.
METABOLITES (2013)
Metabotyping of human colorectal cancer using two-dimensional gas chromatography mass spectrometry
Mainak Mal et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2012)
Regulation of Cell Migration by Sphingomyelin Synthases: Sphingomyelin in Lipid Rafts Decreases Responsiveness to Signaling by the CXCL12/CXCR4 Pathway
Satoshi Asano et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC
Wei Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Eicosanoid signalling pathways in the development and progression of colorectal cancer: novel approaches for prevention/intervention
Mary-Clare Cathcart et al.
CANCER AND METASTASIS REVIEWS (2011)
VEGF as a Biomarker for Metastatic Uveal Melanoma in Humans
Vivian Barak et al.
CURRENT EYE RESEARCH (2011)
Comparative Metabolic Flux Profiling of Melanoma Cell Lines BEYOND THE WARBURG EFFECT
David A. Scott et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Prognostic Value of [18F]-Fluoro-Deoxy-Glucose PET/CT, S100 or MIA for Assessment of Cancer-Associated Mortality in Patients with High Risk Melanoma
Markus Essler et al.
PLOS ONE (2011)
Prediction of gastric cancer metastasis through urinary metabolomic investigation using GC/MS
Jun-Duo Hu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Clinical significance of Phosphatidyl Inositol Synthase overexpression in oral cancer
Jatinder Kaur et al.
BMC CANCER (2010)
Early Detection of Recurrent Breast Cancer Using Metabolite Profiling
Vincent M. Asiago et al.
CANCER RESEARCH (2010)
De novo Lipogenesis Protects Cancer Cells from Free Radicals and Chemotherapeutics by Promoting Membrane Lipid Saturation
Evelien Rysman et al.
CANCER RESEARCH (2010)
Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline
Claus Garbe et al.
EUROPEAN JOURNAL OF CANCER (2010)
Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays
Janice M. Mehnert et al.
HUMAN PATHOLOGY (2010)
Cancer as a metabolic disease
Thomas N. Seyfried et al.
NUTRITION & METABOLISM (2010)
Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer
R. J. DeBerardinis et al.
ONCOGENE (2010)
Quantitative Metabolome Profiling of Colon and Stomach Cancer Microenvironment by Capillary Electrophoresis Time-of-Flight Mass Spectrometry
Akiyoshi Hirayama et al.
CANCER RESEARCH (2009)
Phosphatidylinositol-3-Kinase as a Therapeutic Target in Melanoma
Saadia A. Aziz et al.
CLINICAL CANCER RESEARCH (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Metabolic phenotyping in health and disease
Elaine Holmes et al.
CELL (2008)
HER3 is a determinant for poor prognosis in melanoma
Markus Reschke et al.
CLINICAL CANCER RESEARCH (2008)
Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancer
Michael A. Kiebish et al.
JOURNAL OF LIPID RESEARCH (2008)
Lipid signalling in disease
Matthias P. Wymann et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
A serum metabolomic investigation on hepatocellular carcinoma patients by chemical derivatization followed by gas chromatography/mass spectrometry
Ruyi Xue et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2008)
Melanoma biology and new targeted therapy
Vanessa Gray-Schopfer et al.
NATURE (2007)
Epithelial-mesenchymal transition in development and cancer:: role of phosphatidylinositol 3′ kinase/AKT pathways
L Larue et al.
ONCOGENE (2005)
Prognostic significance of activated Akt expression in melanoma: A clinicopathologic study of 292 cases
DL Dai et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
PI3K/Akt signalling pathway and cancer
JAF Vara et al.
CANCER TREATMENT REVIEWS (2004)
Vascular endothelial growth factor transcriptional activation is mediated by hypoxia-inducible factor 1α, HDM2, and p70S6K1 in response to phosphatidylinositol 3-kinase/AKT signaling
HD Skinner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Phosphoinositide 3-kinase signalling - which way to target?
MP Wymann et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
Characterization and direct quantitation of ceramide molecular species from lipid extracts of biological samples by electrospray ionization tandem mass spectrometry
XL Han
ANALYTICAL BIOCHEMISTRY (2002)
Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases
GM Kraehn et al.
BRITISH JOURNAL OF CANCER (2001)
Cytostatic effect of inostamycin, an inhibitor of cytidine 5 '-diphosphate 1,2-diacyl-sn-glycerol (CDP-DG): Inositol transferase, on oral squamous cell carcinoma cell lines
Y Baba et al.
CELL BIOLOGY INTERNATIONAL (2001)
Inostamycin, an inhibitor of cytidine 5 '-diphosphate 1,2-diacyl-sn-glycerol (CDP-DG): Inositol transferase, suppresses invasion ability by reducing productions of matrix metalloproteinase-2 and-9 and cell motility in HSC-4 tongue carcinoma cell line
Y Baba et al.
CLINICAL & EXPERIMENTAL METASTASIS (2000)